Home › Trials › NCT03251118

Long-term observation of patients with inflammatory bowel disease

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

Target PharmaSolutions, Inc. · NCT03251118

This study is tracking adults and children with inflammatory bowel disease over five years to see how well their treatments are working in real life.

Quick facts

Study typeObservational
Enrollment15000 (estimated)
Ages2 Years and up
SexAll
SponsorTarget PharmaSolutions, Inc. (industry)
Locations37 sites (Lancaster, California and 36 other locations)
Trial IDNCT03251118 on ClinicalTrials.gov

What this trial studies

TARGET-IBD is a 5-year longitudinal observational study focusing on adult and pediatric patients aged 2 and above who are being treated for inflammatory bowel disease (IBD). The study aims to create a comprehensive research registry that captures real-world data on the safety and effectiveness of current and future IBD therapies. Participants will be managed in both academic and community settings, allowing for a diverse representation of treatment outcomes. The study will track patients over time to gather insights into their health and treatment experiences.

Who should consider this trial

Good fit: Ideal candidates include adults and children aged 2 or older diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis who are receiving IBD treatment outside of clinical trials.

Not a fit: Patients who have undergone total abdominal colectomy for ulcerative colitis or indeterminate colitis may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide valuable data to improve treatment strategies and outcomes for patients with inflammatory bowel disease.

How similar studies have performed: Other observational studies in similar contexts have shown success in gathering meaningful data on treatment outcomes for inflammatory bowel diseases.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. Adults and children (age 2 or older) with a diagnosis of Crohn's disease (CD), Ulcerative colitis (UC), or Indeterminate colitis (IBDU) having been prescribed any IBD treatment (initial or subsequent) outside of a clinical trial.
2. Have plans for future visits at the site for continued management of IBD.

Exclusion Criteria:

1. Inability to provide written informed consent/assent.
2. Being enrolled in any interventional study or trial for IBD treatment. Note: Patient may be enrolled in other registries or studies where IBD treatment outcomes are observed and/or reported (such as center-based registries).
3. Prior total abdominal colectomy for UC or IBDU.

Where this trial is running

Lancaster, California and 36 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, Ulcerative colitis, Indeterminate colitis, Digestive System Diseases

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.